Related Articles
Cyclophosphamide augments the anti-tumor efficacy of uracil and tegafur by inhibiting dihydropyrimidine dehydrogenase
Expression of orotate phosphoribosyl transferase in human pancreatic cancer: Implication for the efficacy of uracil and tegafur-based adjuvant chemotherapy
Gemcitabine plus epirubicin in advanced pancreatic cancer: A phase II multicenter trial
Clinical outcome of oral uracil/tegafur (UFT) therapy for patients with hormone refractory prostate cancer
Difference in the emetic control among highly emetogenic chemotherapy regimens: Implementation for appropriate use of aprepitant